Cytokinetics Inc (CYTK): R&D Expense
$416.03M
Year ended 2025-12-31
+20.0%
3-year compound annual growth
+33.8%
5-year compound annual growth
+24.5%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $416.03M | +22.6% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $339.41M | +2.8% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $330.12M | +37.1% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $240.81M | +50.6% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $159.94M | +65.0% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $96.95M | +12.6% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $86.12M | -3.4% | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | $89.14M | -1.3% | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | $90.30M | +50.8% | 2019-03-07, From 2017-01-01 |
| 2016-12-31 | $59.90M | +29.1% | 2018-03-05, From 2016-01-01 |
| 2015-12-31 | $46.40M | +4.4% | 2018-03-05, From 2015-01-01 |
| 2014-12-31 | $44.43M | -10.2% | 2017-03-06, From 2014-01-01 |
| 2013-12-31 | $49.45M | +38.7% | 2016-03-03, From 2013-01-01 |
| 2012-12-31 | $35.64M | -4.1% | 2015-03-06, From 2012-01-01 |
| 2011-12-31 | $37.18M | -2.2% | 2014-03-07, From 2011-01-01 |
| 2010-12-31 | $38.01M | -4.6% | 2013-03-15, From 2010-01-01 |
| 2009-12-31 | $39.84M | n/a | 2012-03-13, From 2009-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Cytokinetics Inc (CYTK) | 2025-12-31 | $416.03M | +22.6% |
| Standard Biotools Inc. (LAB) | 2025-12-31 | $25.99M | -9.9% |
| ARS Pharmaceuticals, Inc. (SPRY) | 2025-12-31 | $13.18M | -32.7% |
| Nurix Therapeutics, Inc. (NRIX) | 2025-11-30 | $316.90M | +43.0% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | $112.21M | -42.5% |
| Siga Technologies Inc (SIGA) | 2025-12-31 | $19.96M | +62.1% |
| ADC Therapeutics SA (ADCT) | 2025-12-31 | $104.00M | -5.1% |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $7.76M | +138.6% |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | $68.73M | -17.6% |
Compare CYTK, LAB, SPRY, NRIX side by side · Screen every company in Pharmaceutical Preparations ↗